本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aura Biosciences, Inc.

6.74
-0.1500-2.18%
盘后6.740.00000.00%17:01 EDT
成交量:20.06万
成交额:135.69万
市值:4.18亿
市盈率:-3.55
高:6.87
开:6.75
低:6.63
收:6.89
数据加载中...
2025/06/18

重要事件披露

Form 8-K - Current report
2025/05/16

重要事件披露

Form 8-K - Current report
2025/05/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/15

重要事件披露

Form 8-K - Current report
2025/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/02

重要事件披露

Form 8-K - Current report
2025/03/24

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/24

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/24

重要事件披露

Form 8-K - Current report
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]